by admin_63069 | Sep 4, 2023 | Related Topics
The FDA approval was based on findings from the phase 3 MAGNITUDE trial.
by admin_63069 | Sep 1, 2023 | Related Topics
“If you do not have access to something or the physician’s not doing a good job, you’re not getting your care.”
by admin_63069 | Aug 29, 2023 | Related Topics
Risk factors for cardiovascular events in those who are initiating androgen deprivation therapy must be assessed.
by admin_63069 | Aug 25, 2023 | Related Topics
Many hospitals and medical centers have a multidisciplinary clinic where you as a patient might see a urologist, a radiation oncologist, and perhaps a medical oncologist on the same visit: medical one-stop shopping.
by admin_63069 | Aug 22, 2023 | Related Topics
Flotufolastat F 18 is now included in the NCCN prostate cancer guideline recommendations for all the same categories as the other PSMA-PET imaging agents approved by the FDA.
by admin_63069 | Aug 18, 2023 | Related Topics
Benefits and general information
